Trastuzumab-related cardiotoxicity in the Herceptin Adjuvant trial - Reply

被引：1

作者：

Suter, Thomas M. ^{[1
]}

Procter, Marion ^{[2
]}

Piccart, Martine J. ^{[3
,4
]}

机构：

[1] Univ Bern, Inselspital, Dept Cardiol, Swiss Cardiovasc Ctr,Bern Univ Hosp, CH-3010 Bern, Switzerland

[2] Frontir Sci, Kincraig, Kigussie, Scotland

[3] Univ Libre Bruxelles, Dept Med, Brussels, Belgium

[4] Univ Libre Bruxelles, Breast Int Grp, Inst Jules Bordet, Brussels, Belgium

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 12期

关键词：

D O I：

10.1200/JCO.2007.15.5838

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2053 / 2054

页数：3

共 8 条

[1] Docus on research: Herceptin and the heart - A molecular modifier of cardiac failure [J].

Chien, KR .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08) :789-790

[2]

HESS OM, 2008, BRAUNWALDS HEART DIS, P561

[3] Inhibition of ErbB2/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes [J].

Pentassuglia, Laura ;

Timolati, Francesco ;

Seifriz, Franziska ;

Abudukadier, Kaisaier ;

Suter, Thomas M. ;

Zuppinger, Christian .

EXPERIMENTAL CELL RESEARCH, 2007, 313 (08) :1588-1601

[4] Oxidative stress reversibly inactivates myocardial enzymes during cardiac arrest [J].

Sharma, Arti B. ;

Sun, Jie ;

Howard, Linda L. ;

Williams, Arthur G., Jr. ;

Mallet, Robert T. .

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (01) :H198-H206

[5]

SLAMON D, 2006, 29 SAN ANT BREAST CA

[6] Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial [J].

Suter, Thomas M. ;

Procter, Marion ;

van Veldhuisen, Dirk J. ;

Muscholl, Michael ;

Bergh, Jonas ;

Carlomagno, Chiara ;

Perren, Timothy ;

Passalacqua, Rodolfo ;

Bighin, Claudia ;

Klijn, Jan G. M. ;

Ageev, Fail T. ;

Hitre, Erika ;

Groetz, Juergen ;

Iwata, Hiroji ;

Knap, Malgorzata ;

Gnant, Michael ;

Muehlbauer, Susanne ;

Spence, Alison ;

Gelber, Richard D. ;

Piccart-Gebhart, Martine J. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) :3859-3865

[7] Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31 [J].

Tan-Chiu, E ;

Yothers, G ;

Romond, E ;

Geyer, CE ;

Ewer, M ;

Keefe, D ;

Shannon, RP ;

Swain, SM ;

Brown, A ;

Fehrenbacher, L ;

Vogel, VG ;

Seay, TE ;

Rastogi, P ;

Mamounas, EP ;

Wolmark, N ;

Bryant, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :7811-7819

[8] Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes [J].

Timolati, Francesco ;

Ott, Daniel ;

Pentassuglia, Laura ;

Giraud, Marie-Noelle ;

Perriard, Jean-Claude ;

Suter, Thomas M. ;

Zuppinger, Christian .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 41 (05) :845-854

← 1 →